Usefulness of the blood chemistry screening associated with DXA imaging in a case of secondary osteoporosis in a young adult

Valerio Massimo Magro, Michele Caturano, Giovanni Scala

DOI: https://doi.org/10.7175/cmi.v11i1.1288

Abstract

Multiple myeloma is rare in young patients and may be undiagnosed or characterized by a significant delay in diagnosis.

We report the association of stage I myeloma (according to Durie-Salmon classification) and osteoporosis in a 37-year-old male patient complaining of worsening pain in the spine. Pain attacks resulted in increases in blood pressure with hypertensive episodes. The investigations (on the basis of an unclear radiological picture and the presence of hypertensive state) led to the diagnosis of low grade osteoporosis. Since the young subject was symptomatic at the diagnosis, we continued evaluations on the basis of imaging data (DXA) and laboratory tests, revealing the presence of multiple myeloma. Clinical, laboratory, and therapeutic implications of this clinical case are discussed.

Keywords

Osteoporosis; Young Patient; Hematologic Tests; Multiple Myeloma

Full Text

HTML PDF

References

  • Jurczyszyn A, Nahi H, Avivi I, et al. Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study. Br J Haematol 2016; 175: 884-91; https://doi.org/10.1111/bjh.14328
  • Mirza F, Canalis E. Management of endocrine disease: Secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 2015; 173: R131-R151; https://doi.org/10.1530/EJE-15-0118
  • Drake MT. Unveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance? J Bone Miner Res 2014; 29: 2529-33; https://doi.org/10.1002/jbmr.2387
  • Murray DL, Seningen JL, Dispenzieri A, et al. Laboratory persistence and clinical progression of small monoclonal abnormalities. Am J Clin Pathol 2012; 138: 609-13; https://doi.org/10.1309/AJCPT6OWWMHITA1Y
  • Dugan LO, Dugan DA, Dugan WM Jr. Back pain: the primrose path – a case report. Indiana Med 1990; 83: 114-6
  • Faiman B, Licata AA. New tools for detecting occult monoclonal gammopathy, a cause of secondary osteoporosis. Cleve Clin J Med 2010; 77: 273-8; https://doi.org/10.3949/ccjm.77a.09091
  • Bours SP, van den Bergh JP, van Geel TA, et al. Secondary osteoporosis and metabolic bone disease in patients 50 years and older with osteoporosis or with a recent clinical fracture: a clinical perspective. Curr Opin Rheumatol 2014; 26: 430-9; https://doi.org/10.1097/BOR.0000000000000074
  • Bours SP, van Geel TA, Geusens PP, et al. Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture. J Clin Endocrinol Metab 2011; 96: 1360-7; https://doi.org/10.1210/jc.2010-2135
  • Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis – 2016 – Executive summary. Endocr Pract 2016; 22 (Suppl 4): 1-42; https://doi.org/10.4158/EP161435.GL; https://doi.org/10.4158/EP161435.ESGL; https://doi.org/10.4158/EP161208.GL
  • Adami S, Bertoldo F, Brandi ML, et al. Guidelines for the diagnosis, prevention and treatment of osteoporosis. Reumatismo 2009; 61: 1-25
  • Harrington J, Sochett E. The child with multiple fractures, what next? Pediatr Clin North Am 2015; 62: 841-55; https://doi.org/10.1016/j.pcl.2015.04.006
  • Järveläinen H, Remes K, Viikari J. A severe osteoporosis in a middle-aged man. Duodecim 1999; 115: 2473-6

Statistics

Abstract: 384 views
HTML: 714 views
PDF: 219 views

Refbacks

  • There are currently no refbacks.